-
WHO Identifies Resomelagon as One Of Six Dengue Drug Candidates with Evidence Supporting Further Clinical Development
LUND, SE / ACCESS Newswire / September 16, 2026 / SynAct Pharma AB (publ) (“SynAct”) (STO:SYNACT), a clinical-stage
Lifestyle Content
Technology
-
Fashion vs. Fascism – Because Democracy Should Always Be In Style
-
Meet BAGend: The Clever Australian Home Accessory Keeping Everyday Life Upright
-
Breeze Blends LLC Brings Gourmet All-Natural Seasonings to the World Food Championship for Third Consecutive Year
-
Alexei Orlov Explains Why Global Brands Cannot Treat Every Market the Same
-
The Learning Code, by Dr Tej. A groundbreaking new book – a practical guide to help your child learn – and thrive.
Entertainment
-
Health Insurance Now Launches Private Health Plan Enrollment Option for Catholic Communities
-
FOLIKL Men’s Hair Longevity Formula Earns Certification from NSF
-
Calgary Luxury Custom Home Builders West Ridge Fine Homes Expand Bespoke Design-to-Build Services into Invermere and Windermere Valley
-
Perrault Construction Expands Energy-Efficient Roofing and Window Replacement Services Across Duluth and Superior Ahead of Severe Winter Season
-
Capital Business Solutions Introduces Altru Connect to Help Cultural Organizations Link Altru to Financial Edge NXT
Health
-
Fashion vs. Fascism – Because Democracy Should Always Be In Style
-
Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast
-
FOCUS Names Mark Phillips Senior Vice President of Business Development
-
Michael H. Kaplan Recognized for 17 Years on PHPA Workers’ Compensation Panel and Advocacy for Professional Athletes
-
Boston Industrial Solutions Introduces Personalized Printing Training
